Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

http://www.wikidata.org/entity/Q46706023

about

TSPO imaging in parkinsonian disorders Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases Role of the Vanins-Myeloperoxidase Axis in Colorectal Carcinogenesis.Redox-based therapeutics in neurodegenerative disease.In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.PDE4B as a microglia target to reduce neuroinflammation.Targeting Oxidative Stress in Central Nervous System Disorders The immune response of the human brain to abdominal surgery.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Neuroinflammation in Neurodegenerative Disorders-a Review.Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress.The emerging role of PET imaging in dementia.Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET.New developments in genetic rat models of Parkinson's disease.The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress Integrated imaging of [C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy H-MRS in amyotrophic lateral sclerosis

P2860

Q26747214-1FF673AA-8BAD-4D7B-8F31-A9C5FC2B69D5 Q33624586-A8BC4DC9-BAF4-40D9-98E9-44D926B5A7CB Q33754814-AADD0D18-3B42-4B73-B04A-7165351E463F Q34535918-A961EC91-B35F-4ADD-9B11-57FA565A33A6 Q34680915-A4D784FC-70E2-4A1C-8290-9F1BCBC12B34 Q36935441-68BE36A4-10DC-48C5-988A-B11D6172449D Q37063225-74BCF28F-AF72-4119-AEEE-4E56918FF95A Q37733601-4214CD29-5342-4908-ACF4-C93ACD55028F Q38796315-5608E1B4-5552-458D-8883-3089B8455F4B Q38918789-536BF3EC-BFB6-44CE-A99A-6F7262EA7C43 Q38933080-B4D40F0A-49BB-4CB9-B808-A876DF2ED798 Q38950036-46A5AA7E-72D7-41E2-A70C-0A8D0138E06B Q39173756-76A1ED51-0580-4A2A-A48D-CB6083A29CB8 Q40965410-86CEF839-A247-42DA-BA14-5115F19D5625 Q41581073-BD8B458D-1BCD-45CE-9F6E-2C779F72C51B Q42368225-05C79A9D-EE56-4978-BF42-906F3EC959C2 Q42701971-1289D157-1717-4541-9D3B-49A463AD86CC Q45338276-B6CC29AB-6619-48DD-A223-797D2C990FF9 Q47260577-C0069D99-66C4-42A1-AD98-EA1988590D9D Q47260664-755DE7D6-F757-4EFA-8B0F-C83DF8A263CC Q48502440-D92AAC54-F4E5-4692-BCDB-B5E94F000AE3 Q55020340-6ACC5C44-2575-4695-947A-01705B44834D Q57649750-A71EB220-4896-4A52-A19C-BB56B24E3119 Q58793142-7462EB81-D37B-4E92-B064-1A310F9A692F

P2860

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

http://www.wikidata.org/entity/Q46706023

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@en

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@nl

type

label

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@en

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@nl

prefLabel

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@en

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@nl

P1433

Q46706023-01E30604-3F2A-488E-9BB7-C0F6415E8983

P1476

Q46706023-731CAC33-6D61-4176-B795-44BA8ECE19E0

P2093

Q46706023-048DF25B-4E50-4C8E-9B28-478A11DD9E25

Q46706023-1F67E6A0-9FC8-4A3C-BE48-8C73BE3A432F

Q46706023-304E5F8B-46F0-4DFE-8273-077FDF5B98A1

Q46706023-32A93C08-E8F9-45DA-9B83-2E11D8A9E8C0

Q46706023-3E6A2DB3-7FB6-436D-9350-514DDB1354C0

Q46706023-45DAF1E8-F5A0-402D-9700-BBDF36621DD9

Q46706023-552BA79F-3A86-45AF-9400-91F77DDC86D6

Q46706023-6851F455-0E8C-4A6E-91EC-CA17670D93E1

Q46706023-88F2CB52-AAC1-4432-B6CB-283B035CC12A

Q46706023-91E1F54D-4780-4A7A-BFB7-82BC088E9E42

P2860

Q46706023-0072EB64-F854-4214-8407-D4C0FFD6D025

Q46706023-090C2A30-9908-4723-AEE1-F05FE018FB97

Q46706023-2695572B-F496-4343-A7D6-9B8EC9B67F88

Q46706023-2E19F0C6-5506-43DB-ABD0-09CEC77E4662

Q46706023-2FCC75E0-3DDE-48F6-A47A-A7BCD0974B13

Q46706023-35794189-D385-4A13-A7D4-C9891A1608B1

Q46706023-3B9B0D99-508E-4031-80A0-675B92FC9D44

Q46706023-448EAB55-93F9-41B5-AA9C-7BD89BC16104

Q46706023-46174820-5931-45CD-A382-1BF8F10B85BD

Q46706023-5880F005-D3CF-4836-B071-ED8D7B9A68BA

P304

Q46706023-AE76554B-CF81-4656-87A6-738ACFC8F08B

P31

Q46706023-A1AFF86A-931E-4CF7-B625-1DD666132679

P356

Q46706023-4DB2FE65-57CF-45BA-B088-711E9B11C76C

P407

Q46706023-8FFC445A-B3E1-475C-9A96-6AB59569EFEC

P433

Q46706023-AF21E90F-ED80-42EC-A6B7-E90D356C7E98

P478

Q46706023-0AC7580A-92BA-4A7C-A6E1-8952E127C40B

P50

Q46706023-85826765-EE5A-4583-854D-E92F84B2B946

Q46706023-AE63B10F-7C5A-4918-88DD-1B45B8970A70

P577

Q46706023-19F436DD-1F95-4608-AEAF-50012BF3FC5B

P698

Q46706023-494E24B7-0F94-4D28-A5DE-840B1E004547

P921

Q46706023-1E82EE6A-F458-4376-93EF-A72AB18128BE

Q46706023-D79C4D49-B89A-46AC-B83E-851DA10CA352

P356

P1433

P1476

Effect of the myeloperoxidase ...... study in Parkinson's disease.

@en

P2093

Alan R Kugler

http://www.w3.org/2001/XMLSchema#string

Andrea Varrone

http://www.w3.org/2001/XMLSchema#string

Anna Kirjavainen

http://www.w3.org/2001/XMLSchema#string

Aurelija Jucaite

http://www.w3.org/2001/XMLSchema#string

Joel A Posener

http://www.w3.org/2001/XMLSchema#string

Juha O Rinne

http://www.w3.org/2001/XMLSchema#string

Katarina Varnäs

http://www.w3.org/2001/XMLSchema#string

Lars Farde

http://www.w3.org/2001/XMLSchema#string

Margaret Minkwitz

http://www.w3.org/2001/XMLSchema#string

Nahid Amini

http://www.w3.org/2001/XMLSchema#string

P2860

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

“Mini-mental state”

Parkinsonism: onset, progression and mortality

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

The medical dictionary for regulatory activities (MedDRA).

Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.

Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.

P304

2687-2700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWV184

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 9

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Per Svenningsson

Christer Halldin

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26137956

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease